Sharon Townson, Chief Scientific Officer at Monte Rosa Therapeutics, Inc. (GLUE), sold 6,000 shares at $23.25 ($140K) on 2026-07-06, disclosed to the SEC on 2026-07-07.
Scheduled sale ($140k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.25 | 5,600 | $130K | 93.1% |
| 2 | $24.13 | 400 | $10K | 6.9% |
| Total | $23.31 avg | 6,000 | $140K | 100% |
| Filing → |
| GLUE | SELL | 2026-06-01 | $119K | — | Filing → |
| GLUE | SELL | 2026-01-05 | $48K | — | Filing → |